Stelexis Therapeutics

About:

Stelexis Therapeutics is a company utilizes pre-cancerous stem cells to discover and develop transformative therapies.

Website: https://www.stelexis.com/

Top Investors: Deerfield, Deerfield Capital Management

Description:

Stelexis Therapeutics is to become the cancer therapeutics company, through the discovery and development of novel drugs, utilizing its proprietary platform to selectively target pre-cancerous stem cells. The company will initially focus on therapeutics for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

Total Funding Amount:

$43M

Headquarters Location:

New York, New York, United States

Founded Date:

2017-01-01

Founders:

Amit Verma, Derrick Rossi, Evripidis Gavathiotis, Roman Perez-Soler, Ulrich Steidl

Number of Employees:

1-10

Last Funding Date:

2019-01-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai